HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.

Abstract
Quantitative polymerase chain reaction (QPCR) for cytomegalovirus (CMV) is emerging as the preferred screening method for detection of CMV viremia in patients following allogeneic bone marrow and peripheral blood stem cell transplant. However, there are currently no universally accepted QPCR treatment thresholds at which to start pre-emptive therapy. We report here results of a pre-emptive therapy strategy using ganciclovir (GCV) 5 mg/kg initiated once daily (ODG) delayed till a threshold CMV load of > or =10 000 copies/ml whole blood in clinically stable patients. Sixty-nine at risk patients underwent allogeneic stem cell transplant. 48/69 (70%) patients had an initial episode of CMV viremia. 5/48 (10%) cleared viremia without requiring treatment. 28/43 (65%) patients requiring treatment initiated treatment with ODG. 17/28 (61%) patients successfully cleared CMV viremia on ODG, 10/28 (36%) patients required dose escalation to twice daily GCV for increasing viral loads. There were two cases of CMV disease (colitis) and no deaths due to CMV disease in patients initiating treatment with ODG. We conclude delaying pre-emptive therapy with ODG until whole blood QPCR> or =10 000 copies/ml is a safe and effective strategy for CMV viremia after allogeneic stem cell transplant in clinically stable patients.
AuthorsL A Verkruyse, G A Storch, S M Devine, J F Dipersio, R Vij
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 37 Issue 1 Pg. 51-6 (Jan 2006) ISSN: 0268-3369 [Print] England
PMID16284613 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • DNA, Viral
  • Ganciclovir
Topics
  • Adult
  • Aged
  • Antiviral Agents (administration & dosage)
  • Bone Marrow Transplantation
  • Cytomegalovirus
  • Cytomegalovirus Infections (blood, etiology, prevention & control)
  • DNA, Viral (blood)
  • Female
  • Ganciclovir (administration & dosage)
  • Hematologic Neoplasms (blood, complications, therapy)
  • Humans
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation
  • Polymerase Chain Reaction
  • Transplantation, Homologous
  • Viral Load (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: